Mustafa Solak

Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He treats medical cases of complex cancers. Solak completed an advanced fellowship at the Hacettepe University Cancer Institute. He also worked at the University of Texas MD Anderson Cancer Center.

Specialization & Approach

Dr. Solak treats various malignancies using evidence-based medical therapies. He treats breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers. His work includes modern therapeutic interventions. These interventions include immunotherapy with Keytruda and targeted therapy.

His approach includes coordinating and administering systemic treatments for various cancer stages. The doctor performs the following procedures:

• Chemotherapy for lung, breast, and ovarian cancers
• Hormone therapy for prostate and breast cancer
• Targeted therapy and immunotherapy for advanced malignancies
• Radioiodine therapy for thyroid disorders
• Supervision of systemic treatments for sarcoma and lymphoma

Work Experience

Dr. Solak has practiced at several medical institutions in Turkey and the United States. His career includes clinical roles at:

• Hisar Hospital Intercontinental, Istanbul
• Medical Park Hospital
• Hitit University Corum Training Hospital
• The University of Texas MD Anderson Cancer Center, USA

Education & Training

The doctor received foundational and specialized training from Turkish medical universities. His academic background includes:

• Medical Degree – Hacettepe University Faculty of Medicine
• Residency in Internal Medicine – Istanbul Sisli Etfal Training and Research Hospital
• Minor Specialization (Fellowship) in Oncology – Hacettepe University Cancer Institute

Diseases Treated

Dr. Solak provides treatment for patients with solid tumors and hematological conditions. He treats the following illnesses:

• Breast, lung, and prostate cancer
• Gastrointestinal malignancies, including stomach, colon, and pancreatic cancer
• Gynecological cancers such as cervical and ovarian tumors
• Head and neck cancers, including thyroid and tongue cancer
• Sarcommas and melanomas
• Brain tumors, including glioblastoma and astrocytoma